Pharmacological mechanisms to attenuate sympathetically induced myocardial ischemia

Cardiovascular Drugs and Therapy
R SchulzG Heusch

Abstract

Distal to a coronary stenosis, resting myocardial blood flow and function can be maintained by a compensatory dilation of the poststenotic vascular bed and an increased collateral blood flow from adjacent coronary vessels. Under this condition, electrical stimulation of cardiac sympathetic nerves, as well as their activation during sympathoexcitatory reflexes and exercise, induces a poststenotic alpha 2-adrenoceptor-mediated coronary constriction and a beta-adrenoceptor-mediated, tachycardia-related redistribution of blood flow away from the ischemia myocardium. Thus, activation of cardiac sympathetic nerves can precipitate poststenotic myocardial ischemia. In experimental studies in anesthetized, vagotomized dogs, as well as in conscious, chronically instrumented dogs, selective alpha 2-adrenoceptor antagonists and calcium-channel blockade with nifedipine were able to attenuate the sympathetically induced poststenotic myocardial ischemia. Beta-adrenoceptor blockade with atenolol was only proven beneficial as long as there was a heart-rate reduction. Conversely, a specific bradycardic agent (ULFS-49) also exerted beneficial effects. Myocardial ischemia can activate cardiac sympathetic afferents and then, by a spinal reflex, can...Continue Reading

References

Jun 1, 1976·The American Journal of Physiology·F N Hamilton, E O Feigl
Jan 1, 1978·Reviews of Physiology, Biochemistry and Pharmacology· Kobinger
Jul 1, 1976·Journal of Applied Physiology·M J Denn, H L Stone
Nov 1, 1985·Journal of Cardiovascular Pharmacology·G HeuschV Thämer
Dec 1, 1987·Journal of Cardiovascular Pharmacology·J SchipkeV Thämer
Nov 1, 1987·Progress in Cardiovascular Diseases·M A YoungS F Vatner
Feb 1, 1986·The American Journal of Cardiology·G M BerkenboomS G Degre
Aug 1, 1974·The Journal of Clinical Investigation·S F Vatner
Apr 1, 1971·The Journal of Clinical Investigation·D R McRavenH E Mayer
Jul 8, 1972·British Medical Journal·S W WebbJ F Pantridge
May 1, 1968·Circulation Research·W M Fam, M McGregor
Jun 1, 1971·Circulation Research·W SchaperP Lewi
Jan 31, 1969·Annals of the New York Academy of Sciences·E T AngelakosR W Millard
Sep 1, 1969·The American Journal of Physiology·A MallianiA Zanchetti
Nov 1, 1983·Journal of Molecular and Cellular Cardiology·P A van Zwieten, P B Timmermans
Sep 1, 1984·Circulation Research·H J MotulskyP A Insel
May 1, 1984·Journal of Cardiovascular Pharmacology·G Heusch, A Deussen
Mar 1, 1980·Circulation Research·C van Breemen, B Siegel
Nov 1, 1980·Naunyn-Schmiedeberg's Archives of Pharmacology·J W Constantine, W Lebel
Aug 27, 1982·European Journal of Pharmacology·J HoltzE Bassenge
Jan 1, 1983·Physiological Reviews·E O Feigl

❮ Previous
Next ❯

Citations

Dec 5, 2003·Lancet·Wolfgang Buhre, Rolf Rossaint
Apr 1, 1992·International Journal of Cardiology·H KishidaT Saito
Feb 1, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Eduard I DedkovRobert J Tomanek

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.